Eps Summary of Abliva AB (publ)

Abliva AB (publ)'s latest annual eps in 2023 was -0.09 SEK , up 19.09% from previous year.
Abliva AB (publ)'s latest quarterly eps in 2024 Q2 was -0.00 USD , down -18.6% from previous quarter.
Abliva AB (publ) reported an annual eps of -0.01 USD in 2022, up 69.27% from previous year.
Abliva AB (publ) reported an annual eps of -0.04 USD in 2021, down -25.61% from previous year.
Abliva AB (publ) reported a quarterly eps of -0.00 USD for 2024 Q1, up 28.03% from previous quarter.
Abliva AB (publ) reported a quarterly eps of N/A for 2023 FY, up 19.09% from previous quarter.

Annual Eps Chart of Abliva AB (publ) (2023 - 2007)

Historical Annual Eps of Abliva AB (publ) (2023 - 2007)

Year	Eps	Eps Growth
2023	-0.09 SEK	19.09%
2022	-0.01 USD	69.27%
2021	-0.04 USD	-25.61%
2020	-0.03 USD	39.1%
2019	-0.05 USD	46.02%
2018	-0.09 SEK	33.31%
2017	-0.13 SEK	13.33%
2016	-0.15 SEK	40.0%
2015	-0.25 SEK	79.67%
2014	-1.23 SEK	-41.38%
2013	-0.87 SEK	-35.94%
2012	-0.64 SEK	-45.45%
2011	-0.44 SEK	-91.3%
2010	-0.23 SEK	-219.44%
2009	-0.07 SEK	6.86%
2008	-0.08 SEK	-33.97%
2007	-0.06 SEK	0.0%

Year	Eps	Eps Growth
2024 Q2	-0.00 USD	-18.6%
2024 Q1	-0.00 USD	28.03%
2023 FY	- USD	19.09%
2023 Q2	-0.00 USD	-26.67%
2023 Q3	-0.00 USD	-47.37%
2023 Q4	-0.00 USD	14.29%
2023 Q1	-0.00 USD	6.25%
2022 Q2	-0.00 SEK	22.81%
2022 Q3	-0.00 USD	18.18%
2022 Q4	-0.00 USD	55.56%
2022 FY	- USD	69.27%
2022 Q1	-0.01 SEK	41.84%
2021 Q3	-0.01 SEK	-5.49%
2021 Q4	-0.01 SEK	-2.08%
2021 Q1	-0.01 SEK	79.75%
2021 Q2	-0.01 SEK	-12.35%
2021 FY	- USD	-25.61%
2020 Q3	-0.03 SEK	49.93%
2020 Q4	-0.04 SEK	-19.4%
2020 FY	- USD	39.1%
2020 Q1	-0.10 SEK	34.93%
2020 Q2	-0.07 SEK	31.45%
2019 Q2	-0.14 SEK	-93.1%
2019 FY	- USD	46.02%
2019 Q1	-0.07 SEK	71.0%
2019 Q3	-0.08 SEK	44.21%
2019 Q4	-0.15 SEK	-92.06%
2018 Q1	-0.24 SEK	-26.32%
2018 Q2	-0.39 SEK	-62.5%
2018 Q3	-0.20 SEK	48.72%
2018 Q4	-0.25 SEK	-25.0%
2018 FY	- SEK	33.31%
2017 Q4	-0.19 SEK	17.39%
2017 Q3	-0.23 SEK	42.5%
2017 Q2	-0.40 SEK	-25.0%
2017 Q1	-0.32 SEK	5.88%
2017 FY	- SEK	13.33%
2016 Q2	-0.19 SEK	32.14%
2016 Q1	-0.28 SEK	-27.27%
2016 Q3	-0.68 SEK	-257.89%
2016 FY	- SEK	40.0%
2016 Q4	-0.34 SEK	50.0%
2015 Q1	-0.39 SEK	33.9%
2015 Q3	-1.38 SEK	-220.93%
2015 Q4	-0.22 SEK	84.06%
2015 Q2	-0.43 SEK	-10.26%
2015 FY	- SEK	79.67%
2014 Q4	-0.59 SEK	-501.43%
2014 FY	- SEK	-41.38%
2014 Q1	-0.31 SEK	31.11%
2014 Q2	-0.38 SEK	-22.58%
2014 Q3	-0.10 SEK	74.18%
2013 Q1	-0.19 SEK	1.04%
2013 FY	- SEK	-35.94%
2013 Q4	-0.45 SEK	-73.08%
2013 Q3	-0.26 SEK	-116.67%
2013 Q2	-0.12 SEK	36.84%
2012 Q2	-0.18 SEK	-38.46%
2012 Q1	-0.13 SEK	-4.84%
2012 FY	- SEK	-45.45%
2012 Q4	-0.19 SEK	-37.14%
2012 Q3	-0.14 SEK	22.22%
2011 Q4	-0.12 SEK	-3.33%
2011 FY	- SEK	-91.3%
2011 Q2	-0.15 SEK	-136.59%
2011 Q1	-0.06 SEK	-0.63%
2011 Q3	-0.12 SEK	20.0%
2010 Q1	-0.04 SEK	-107.89%
2010 FY	- SEK	-219.44%
2010 Q3	-0.07 SEK	-20.77%
2010 Q2	-0.06 SEK	-43.8%
2010 Q4	-0.06 SEK	8.16%
2009 FY	- SEK	6.86%
2009 Q2	-0.02 SEK	-6.35%
2009 Q1	-0.02 SEK	0.0%
2009 Q3	-0.01 SEK	27.36%
2009 Q4	-0.02 SEK	-30.14%
2008 FY	- SEK	-33.97%
2007 FY	- SEK	0.0%

Peer Eps Comparison of Abliva AB (publ)

Name	Eps	Eps Difference
Bioxytran, Inc.	-0.03 USD	-183.386%
Eiger BioPharmaceuticals, Inc.	-50.78 USD	99.822%
Institute of Biomedical Research Corp.	-0.05 USD	-75.534%
SQZ Biotechnologies Company	-2.76 USD	96.725%
Intellipharmaceutics International Inc.	-0.09 USD	-3.432%
Evofem Biosciences, Inc.	10.35 USD	100.873%
Santhera Pharmaceuticals Holding AG	5.95 USD	101.519%
Propanc Biopharma, Inc.	-0.02 USD	-281.435%
Marizyme, Inc.	-1.44 USD	93.722%
Genus plc	0.12 USD	175.333%
Pharming Group N.V.	-0.02 USD	-461.491%
Therapeutic Solutions International, Inc.	-0.00 USD	-12814.286%
CNBX Pharmaceuticals Inc.	-0.42 USD	78.476%
Nymox Pharmaceutical Corporation	-0.10 USD	6.321%
ContraFect Corporation	-124.97 USD	99.928%
RegeneRx Biopharmaceuticals, Inc.	-0.01 USD	-653.333%
IMV Inc.	-4.37 USD	97.931%
AXIM Biotechnologies, Inc.	-0.04 USD	-155.367%
ONE Bio Corp.	1.43 USD	106.322%
RVL Pharmaceuticals plc	-0.58 USD	84.414%
Mesoblast Limited	-0.09 USD	-1.459%
MultiCell Technologies, Inc.	-0.00 USD	-90300.0%
Arno Therapeutics, Inc.	- USD	Infinity%
Emmaus Life Sciences, Inc.	-0.07 USD	-28.592%
Genscript Biotech Corporation	-0.05 USD	-99.119%
Neon Bloom, Inc.	-0.00 USD	-5926.667%
Mosaic ImmunoEngineering Inc.	-0.33 USD	72.606%
Nanobac Pharmaceuticals, Incorporated	- USD	Infinity%
Biomind Labs Inc.	-0.02 USD	-458.025%
Provectus Biopharmaceuticals, Inc.	-0.01 USD	-1121.622%
Oncotelic Therapeutics, Inc.	-0.02 USD	-354.271%
Skye Bioscience, Inc.	-5.37 USD	98.317%
GlobeStar Therapeutics Corporation	-0.00 USD	-3666.667%
VioQuest Pharmaceuticals, Inc.	-2.33 USD	96.12%
THC Farmaceuticals, Inc.	-0.00 USD	-11200.0%
PsyBio Therapeutics Corp.	-0.04 USD	-115.238%
Arch Therapeutics, Inc.	-2.27 USD	96.018%
Sienna Biopharmaceuticals, Inc.	- USD	Infinity%
Acro Biomedical Co., Ltd.	-0.26 USD	65.231%
Accustem Sciences Inc.	-0.34 USD	73.412%
EV Biologics, Inc.	-0.12 USD	24.667%
Q BioMed Inc.	-0.08 USD	-15.749%
GB Sciences, Inc.	-0.00 USD	-2104.878%
Alpha Cognition Inc.	-0.15 USD	39.733%
CSL Limited	2.73 USD	103.311%
Agentix Corp.	-0.04 USD	-158.286%
American Oriental Bioengineering, Inc.	-781.24 USD	99.988%
Enzolytics Inc.	-0.00 USD	-12814.286%
TetraLogic Pharmaceuticals Corporation	- USD	Infinity%
Resverlogix Corp.	-0.01 USD	-536.62%
Nuo Therapeutics, Inc.	-0.08 USD	-19.894%
MetaStat, Inc.	- USD	Infinity%
Curative Biotechnology, Inc.	-0.01 USD	-927.273%
argenx SE	-5.16 USD	98.248%
Northwest Biotherapeutics, Inc.	-0.06 USD	-57.217%
HST Global, Inc.	-0.03 USD	-224.014%
Enzon Pharmaceuticals, Inc.	0.00 USD	7053.846%
Wesana Health Holdings Inc.	-0.05 USD	-80.439%
Halberd Corporation	-0.00 USD	-90300.0%
Endonovo Therapeutics, Inc.	0.03 USD	460.159%
Inhibitor Therapeutics, Inc.	-0.02 USD	-352.0%
Zenith Capital Corp.	-0.07 USD	-29.328%
RespireRx Pharmaceuticals Inc.	-0.04 USD	-153.221%
GeneThera, Inc.	- USD	Infinity%
Sigyn Therapeutics, Inc.	-3.77 USD	97.602%
AVAX Technologies, Inc.	-0.05 USD	-67.718%
WPD Pharmaceuticals Inc.	-0.00 USD	-17980.0%
Cotinga Pharmaceuticals Inc.	-0.09 USD	0.986%
Ember Therapeutics, Inc.	-0.01 USD	-1334.921%
Anthera Pharmaceuticals, Inc.	- USD	Infinity%
Adynxx, Inc.	- USD	Infinity%
NovAccess Global Inc.	-0.23 USD	60.696%
Helix BioMedix, Inc.	-4.70 USD	98.077%
Capstone Therapeutics Corp.	-36.39 USD	99.752%
Kadimastem Ltd	-0.78 USD	88.41%
VitaSpring Biomedical Co. Ltd.	- USD	Infinity%
BioStem Technologies, Inc.	-0.62 USD	85.419%
Oncology Pharma Inc.	- USD	Infinity%
Reve Technologies, Inc.	-0.01 USD	-659.664%
Burzynski Research Institute, Inc.	-0.01 USD	-786.275%
LadRx Corporation	0.68 USD	113.294%
Cell Source, Inc.	-0.17 USD	46.824%
ProtoKinetix, Incorporated	-0.01 USD	-804.0%
Regen BioPharma, Inc.	0.29 USD	131.172%
Regen BioPharma, Inc.	0.26 USD	134.769%
Affymax, Inc.	-0.39 USD	76.821%
Mobile Lads Corp.	-0.01 USD	-1514.286%
Itoco Inc.	-0.01 USD	-1089.474%
Rasna Therapeutics, Inc.	-0.01 USD	-804.0%
Pathfinder Cell Therapy, Inc.	-0.00 USD	-3516.0%
International Stem Cell Corporation	-0.02 USD	-451.22%
CytoDyn Inc.	-0.05 USD	-70.888%
Claritas Pharmaceuticals, Inc.	- USD	Infinity%
NDT Pharmaceuticals Inc.	-0.00 USD	-17980.0%
NanoSphere Health Sciences Inc.	-0.02 USD	-307.207%
Qrons Inc.	-0.06 USD	-55.06%
Alseres Pharmaceuticals, Inc.	-153.67 USD	99.941%
SYBLEU INC	-0.02 USD	-416.571%
Advanced Proteome Therapeutics Corporation	- USD	Infinity%
Nascent Biotech, Inc.	-0.01 USD	-574.627%
Rebus Holdings, Inc.	-0.03 USD	-181.62%
GlobeImmune, Inc.	- USD	Infinity%
ImmunoCellular Therapeutics, Ltd.	-0.01 USD	-536.62%
Predictive Technology Group, Inc.	- USD	Infinity%
ProText Mobility, Inc.	- USD	Infinity%
Cardax, Inc.	- USD	Infinity%
VG Life Sciences Inc.	-0.00 USD	-90300.0%
Kaleido Biosciences, Inc.	- USD	Infinity%
Advaxis, Inc.	-7.99 USD	98.869%
Adhera Therapeutics, Inc.	-1.18 USD	92.339%
RenovaCare, Inc.	- USD	Infinity%
Regnum Corp.	-0.03 USD	-165.882%
Innovation Pharmaceuticals Inc.	-0.01 USD	-1334.921%
Neutra Corp.	-0.00 USD	-90300.0%
Windtree Therapeutics, Inc.	-94.23 USD	99.904%
PureTech Health plc	-2.38 USD	96.202%
Coeptis Therapeutics, Inc.	-0.83 USD	89.108%
IXICO plc	-0.02 USD	-270.492%
IntelGenx Technologies Corp.	-0.06 USD	-59.155%
Gelesis Holdings, Inc.	-1.35 USD	93.304%
CSL Limited	5.47 USD	101.653%
Cellectis S.A.	-1.77 USD	94.893%

Global Stocks Search

Abliva AB (publ) (NEVPF)

Eps Summary of Abliva AB (publ)

Annual Eps Chart of Abliva AB (publ) (2023 - 2007)

Historical Annual Eps of Abliva AB (publ) (2023 - 2007)

Peer Eps Comparison of Abliva AB (publ)